Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Elevated levels of C-reactive protein (CRP) are associated with increased risks of ischemic heart disease and ischemic cerebrovascular disease. We tested whether this is a causal association. METHODS: We studied 10,276 persons from a general population cohort, including 1786 in whom ischemic heart disease developed and 741 in whom ischemic cerebrovascular disease developed. We examined another 31,992 persons from a cross-sectional general population study, of whom 2521 had ischemic heart disease and 1483 had ischemic cerebrovascular disease. Finally, we compared 2238 patients with ischemic heart disease with 4474 control subjects and 612 patients with ischemic cerebrovascular disease with 1224 control subjects. We measured levels of high-sensitivity CRP and conducted genotyping for four CRP polymorphisms and two apolipoprotein E polymorphisms. RESULTS: The risk of ischemic heart disease and ischemic cerebrovascular disease was increased by a factor of 1.6 and 1.3, respectively, in persons who had CRP levels above 3 mg per liter, as compared with persons who had CRP levels below 1 mg per liter. Genotype combinations of the four CRP polymorphisms were associated with an increase in CRP levels of up to 64%, resulting in a theoretically predicted increased risk of up to 32% for ischemic heart disease and up to 25% for ischemic cerebrovascular disease. However, these genotype combinations were not associated with an increased risk of ischemic vascular disease. In contrast, apolipoprotein E genotypes were associated with both elevated cholesterol levels and an increased risk of ischemic heart disease. CONCLUSIONS: Polymorphisms in the CRP gene are associated with marked increases in CRP levels and thus with a theoretically predicted increase in the risk of ischemic vascular disease. However, these polymorphisms are not in themselves associated with an increased risk of ischemic vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional biomarkers, including apo B, lipoprotein(a), high-sensitivity C-reactive protein (CRP), coronary artery calcification score, and ankle-brachial index, are independent risk factors associated with increased risk of ASCVD events and may be helpful when the lipid management goal is unclear.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [284]
In the citing paper
“The value of hsCRP as a CV risk factor appears similar to that of conventional CV risk factors – hsCRP is not a causal factor for CV disease and serves as a biomarker only [36].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [36]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“PAD is a common manifestation of atherosclerosis and such patients are at elevated risk of coronary events, with PAD representing an independent risk factor for MI and CV death [510,511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
In the citing paper
“Yet, despite the high CV morbidity and mortality risk, PAD patients are usually inadequately managed compared with CAD patients [511].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [511]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Davey Smith, G., & Ebrahim, S. (2003) · International Journal of Epidemiology · doi:10.1093/ije/dyg070 · Cited by 5,882
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Clinical application of C-reactive protein for cardiovascular disease detection and prevention
Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000053730.47739.3c · Cited by 2,513
Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Self-citationFasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Willer, C. J., Sanna, S., Jackson, A. U., Scuteri, A., Bonnycastle, L. L., Clarke, R., Heath, S. C., Timpson, N. J., Najjar, S. S., Stringham, H. M., et al. (2008) · Nature Genetics · doi:10.1038/ng.76 · Cited by 1,585
Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N. P., Rieder, M. J., Cooper, G. M., Roos, C., Voight, B. F., Havulinna, A. S., et al. (2008) · Nature Genetics · doi:10.1038/ng.75 · Cited by 1,386
Mendelian randomization: prospects, potentials, and limitations
Smith, G. D. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh132 · Cited by 1,222
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Cited by
Items 101–200 of 840
Pooley, K. A., Bojesen, S. E., Weischer, M., Nielsen, S. F., Thompson, D., Amin Al Olama, A., Michailidou, K., Tyrer, J. P., Benlloch, S., Brown, J., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt355 · Cited by 140
Self-citationErnst, G. D. S., de Jonge, L. L., Hofman, A., Lindemans, J., Russcher, H., Steegers, E. A. P., & Jaddoe, V. W. V. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.03.049 · Cited by 138
Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases
Pretorius, E., & Kell, D. B. (2014) · Integrative Biology · doi:10.1039/c4ib00025k · Cited by 151
Inflammatory Concepts of Obesity
Rocha, V. Z., & Folco, E. J. E. (2011) · International Journal of Inflammation · doi:10.4061/2011/529061 · Cited by 151
IL-6 and Cardiovascular Risk: A Narrative Review
Mehta, N. N., deGoma, E. M., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01259-7 · Cited by 153
Loss‐of‐function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
Nordestgaard, L. T., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.04.006 · Cited by 139
Self-citationPedersen, E. R., Midttun, Ø., Ueland, P. M., Schartum-Hansen, H., Seifert, R., Igland, J., Nordrehaug, J. E., Ebbing, M., Svingen, G., Bleie, Ø., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.219329 · Cited by 137
Lipids, Lipoproteins, Apolipoproteins, and Other Cardiovascular Risk Factors
Remaley, A. T., Rifai, N., & Warnick, G. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00027-5 · Cited by 144
Catapano, A. L., Pirillo, A., & Norata, G. D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13805 · Cited by 137
Jensen, M. T., Marott, J. L., Allin, K. H., Nordestgaard, B. G., & Jensen, G. B. (2012) · European Journal of Preventive Cardiology · doi:10.1177/1741826710394274 · Cited by 134
Self-citationSmoking and HIV: Prevalence, Health Risks, and Cessation Strategies
Lifson, A. R., & Lando, H. A. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0121-0 · Cited by 142
Habersberger, J., Strang, F., Scheichl, A., Htun, N., Bassler, N., Merivirta, R., Diehl, P., Krippner, G. Y., Meikle, P. J., Eisenhardt, S. U., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs237 · Cited by 145
Benn, M., & Nordestgaard, B. G. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy045 · Cited by 130
Self-citationBorges, Á. H., O’Connor, J. L., Phillips, A. N., Neaton, J. D., Grund, B., Neuhaus, J., Vjecha, M. J., Calmy, A., Koelsch, K. K., & Lundgren, J. D. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw173 · Cited by 147
Plasma YKL-40 levels in healthy subjects from the general population
Bojesen, S. E., Johansen, J. S., & Nordestgaard, B. G. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.01.022 · Cited by 130
Self-citationMonitoring of inflammation in patients on dialysis: forewarned is forearmed
Meuwese, C. L., Stenvinkel, P., Dekker, F. W., & Carrero, J. J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.2 · Cited by 139
Inflammation in Coronary Artery Disease
Christodoulidis, G., Vittorio, T. J., Fudim, M., Lerakis, S., & Kosmas, C. E. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000006 · Cited by 137
Idicula, T. T., Brogger, J., Naess, H., Waje-Andreassen, U., & Thomassen, L. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-18 · Cited by 122
A Mendelian randomization study of the effect of type-2 diabetes on coronary heart disease
Ahmad, O. S., Morris, J. A., Mujammami, M., Forgetta, V., Leong, A., Li, R., Turgeon, M., Greenwood, C. M. T., Thanassoulis, G., Meigs, J. B., et al. (2015) · Nature Communications · doi:10.1038/ncomms8060 · Cited by 123
Mendelian Randomization as a Tool for Cardiovascular Research: A Review
Levin, M. G., & Burgess, S. (2023) · JAMA Cardiology · doi:10.1001/jamacardio.2023.4115 · Cited by 129
Fabrication of Oriented Antibody-Conjugated Magnetic Nanoprobes and Their Immunoaffinity Application
Lin, P., Chen, S., Wang, K., Chen, M., Adak, A. K., Hwu, J. R., Chen, Y., & Lin, C. (2009) · Analytical Chemistry · doi:10.1021/ac9012122 · Cited by 123
Cardiorespiratory fitness and the metabolic syndrome: Roles of inflammation and abdominal obesity
Wedell-Neergaard, A.-S., Krogh-Madsen, R., Petersen, G. L., Hansen, Å. M., Pedersen, B. K., Lund, R., & Bruunsgaard, H. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194991 · Cited by 113
Inflammation in Renal Transplantation
Abedini, S., Holme, I., Diaeresis]rz, W. M., Weihrauch, G., Diaeresis]m, B. F., Jardine, A. G., Cole, E., Maes, B., Neumayer, H., Grönhagen‐Riska, C., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00930209 · Cited by 133
Biomarkers and Cardiovascular Risk Assessment for Primary Prevention: An Update
Gilstrap, L. G., & Wang, T. J. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.165712 · Cited by 121
Li, J., Zhao, X., Meng, X., Lin, J., Liu, L., Wang, C., Wang, A., Wang, Y., Wang, Y., & on behalf of the CHANCE Investigators (2016) · Stroke · doi:10.1161/strokeaha.116.012901 · Cited by 133
The Evolving Role of Inflammatory Biomarkers in Risk Assessment After Stent Implantation
Niccoli, G., Montone, R. A., Ferrante, G., & Crea, F. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.045 · Cited by 133
Scheller Madrid, A., Rode, L., Nordestgaard, B. G., & Bojesen, S. E. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.258566 · Cited by 121
Self-citationInterleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis
Hettwer, J., Hinterdobler, J., Miritsch, B., Deutsch, M.-A., Li, X., Mauersberger, C., Moggio, A., Braster, Q., Gram, H., Robertson, A. A. B., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvab337 · Cited by 111
C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study
Allin, K. H., Nordestgaard, B. G., Zacho, J., Tybjærg-Hansen, A., & Bojesen, S. E. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp459 · Cited by 117
Self-citationRosuvastatin in Diabetic Hemodialysis Patients
Holdaas, H., Holme, I., Schmieder, R. E., Jardine, A. G., Zannad, F., Norby, G. E., & Fellström, B. C. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090987 · Cited by 118
Effects of hormonal contraception on systemic metabolism: cross-sectional and longitudinal evidence
Wang, Q., Würtz, P., Auro, K., Morin-Papunen, L., Kangas, A. J., Soininen, P., Tiainen, M., Tynkkynen, T., Joensuu, A., Havulinna, A. S., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw147 · Cited by 117
CRP and suPAR are differently related to anthropometry and subclinical organ damage
Lyngbæk, S., Sehestedt, T. B., Marott, J. L., Hansen, T. W., Olsen, M. H., Andersen, O., Linneberg, A. R., Madsbad, S., Haugaard, S. B., Eugen‐Olsen, J., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.040 · Cited by 121
“The exact role of CRP in the atherosclerotic process is unclear, but recent studies using Mendelian randomization have shown that genetically elevated levels of CRP are not associated with increased CVD risk, suggesting that CRP is merely a risk marker rather than a causal factor in the atherosclerotic process [3,4].”
BackgroundsuPAR: A New Biomarker for Cardiovascular Disease?
Hodges, G. W., Bang, C. N., Wachtell, K., Eugen‐Olsen, J., & Jeppesen, J. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.03.023 · Cited by 127
Venous Thromboembolism and Risk of Idiopathic Interstitial Pneumonia: A Nationwide Study
Sode, B. F., Dahl, M., Nielsen, S. F., & Nordestgaard, B. G. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200912-1951oc · Cited by 113
Self-citationScott, R. A., Freitag, D. F., Li, L., Chu, A. Y., Surendran, P., Young, R., Grarup, N., Stancáková, A., Chen, Y., Varga, T. V., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad3744 · Cited by 118
Self-citationMauras, N., DelGiorno, C., Kollman, C., Bird, K., Morgan, M., Sweeten, S., Balagopal, P., & Damaso, L. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1887 · Cited by 111
C-reactive protein and all-cause mortality--the Copenhagen City Heart Study
Zacho, J., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq103 · Cited by 113
Self-citationMultimarker Prediction of Coronary Heart Disease Risk
Kim, H. C., Greenland, P., Rossouw, J. E., Manson, J. E., Cochrane, B. B., Lasser, N. L., Limacher, M. C., Lloyd‐Jones, D. M., Margolis, K. L., & Robinson, J. G. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.047 · Cited by 126
KONES, R. J. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10812 · Cited by 141
Helleberg, M., Gerstoft, J., Afzal, S., Kronborg, G., Larsen, C. S., Pedersen, C., Bojesen, S. E., Nordestgaard, B. G., & Obel, N. (2014) · AIDS · doi:10.1097/qad.0000000000000283 · Cited by 114
Self-citationNielsen, C., Birgens, H. S., Nordestgaard, B. G., & Bojesen, S. E. (2013) · British Journal of Haematology · doi:10.1111/bjh.12099 · Cited by 109
Self-citationStatins and inflammation: an update
Quist‐Paulsen, P. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283398e53 · Cited by 124
Wium-Andersen, M. K., Ørsted, D. D., & Nordestgaard, B. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.009 · Cited by 93
Self-citationKemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.033 · Cited by 109
Adipokines and cardiovascular disease: A comprehensive review
Smekal, A., & Vaclavik, J. (2017) · Biomedical Papers · doi:10.5507/bp.2017.002 · Cited by 105
Gurven, M., Kaplan, H., Winking, J., Eid Rodriguez, D., Vasunilashorn, S., Kim, J. K., Finch, C., & Crimmins, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006590 · Cited by 107
Nielsen, C., Bojesen, S. E., Nordestgaard, B. G., Kofoed, K. F., & Birgens, H. S. (2014) · Haematologica · doi:10.3324/haematol.2014.107631 · Cited by 106
Self-citationIncreased Body Mass Index, Elevated C-reactive Protein, and Short Telomere Length
Rode, L., Nordestgaard, B. G., Weischer, M., & Bojesen, S. E. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1161 · Cited by 116
Self-citationHaase, C. L., Tybjærg-Hansen, A., Grande, P., & Frikke-Schmidt, R. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0450 · Cited by 104
Self-citationBoncler, M. A., Wu, Y., & Watała, C. W. (2019) · Molecules · doi:10.3390/molecules24112062 · Cited by 120
Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk
Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.01.049 · Cited by 103
Self-citationA scheme for a flexible classification of dietary and health biomarkers
Gao, Q., Praticò, G., Scalbert, A., Vergères, G., Kolehmainen, M., Manach, C., Brennan, L., Afman, L. A., Wishart, D. S., Andrés‐Lacueva, C., et al. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0587-x · Cited by 110
C-reactive protein: Risk factor, biomarker and/or therapeutic target?
Genest, J. J. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)71061-8 · Cited by 118
Human C-Reactive Protein Does Not Promote Atherosclerosis in Transgenic Rabbits
Koike, T., Kitajima, S., Yu, Y., Nishijima, K., Zhang, J., Ozaki, Y., Morimoto, M., Watanabe, T., Bhakdi, S., Asada, Y., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.872796 · Cited by 104
on behalf of the FinnDiane Study Group, Hansen, T. K., Forsblom, C. M., Saraheimo, M., Thorn, L. M., Wadén, J., Høyem, P., Østergaard, J. A., Flyvbjerg, A., & Groop, P. (2010) · Diabetologia · doi:10.1007/s00125-010-1742-8 · Cited by 108
Lipids, atherosclerosis and CVD risk: Is CRP an innocent bystander?
Nordestgaard, B. G., & Zacho, J. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.07.005 · Cited by 101
Self-citationBiochemistry and Biomarkers of Inflamed Patients: Why Look, What to Assess
Kaysen, G. A. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03090509 · Cited by 100
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction
Sabbah, M. S., Fayyaz, A. U., de Denus, S., Felker, G. M., Borlaug, B. A., Dasari, S., Carter, R. E., & Redfield, M. M. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006414 · Cited by 98
Mechanisms of Lipoprotein(a) Pathogenicity
Spence, J. D., & Koschinsky, M. L. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.251306 · Cited by 100
Whiteley, W. N., Jackson, C., Lewis, S. C., Lowe, G. D. O., Rumley, A., Sandercock, P. A., Wardlaw, J. M., Dennis, M. S., & Sudlow, C. L. M. (2010) · Stroke · doi:10.1161/strokeaha.110.588954 · Cited by 107
Personalized Intervention Based on Early Detection of Atherosclerosis
Nielsen, R. V., Fuster, V., Bundgaard, H., Fuster, J. J., Johri, A. M., Kofoed, K. F., Douglas, P. S., Diederichsen, A. C. P., Shapiro, M. D., Nicholls, S. J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.053 · Cited by 104
Self-citationBlaha, M. J., Rivera, J. J., Budoff, M. J., Blankstein, R., Agatston, A., O'Leary, D. H., Cushman, M., Lakoski, S., Criqui, M. H., Szklo, M., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.223768 · Cited by 99
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
Pirillo, A., Bonacina, F., Norata, G. D., & Catapano, A. L. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0715-0 · Cited by 101
Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis
Bjørngaard, J. H., Nordestgaard, A. T., Taylor, A. E., Treur, J. L., Gabrielsen, M. E., Munafo, M. R., Nordestgaard, B. G., Åsvold, B. O., Romundstad, P., & Smith, G. D. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx147 · Cited by 102
Self-citationRosenson, R. S., Hislop, C., Elliott, M. D., Stasiv, Y., Goulder, M. A., & Waters, D. D. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.06.015 · Cited by 95
Mazhar, F., Faucon, A., Fu, E. L., Szummer, K. E., Mathisen, J., Gerward, S., Reuter, S. B., Marx, N., Mehran, R., & Carrero, J. J. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae557 · Cited by 99
Mendelian Randomisation Study of Childhood BMI and Early Menarche
Mumby, H. S., Elks, C. E., Li, S., Sharp, S. J., Khaw, K.-T., Luben, R. N., Wareham, N. J., Loos, R. J. F., & Ong, K. K. (2011) · Journal of Obesity · doi:10.1155/2011/180729 · Cited by 94
Singh‐Manoux, A., Shipley, M. J., Bell, J. A., Canonico, M., Elbaz, A., & Mika Kivimaki, B. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.160313 · Cited by 96
Sigurdardottir, F. D., Lyngbakken, M. N., Holmen, O. L., Dalen, H., Hveem, K., Røsjø, H. R., & Omland, T. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.004 · Cited by 100
Mosenzon, O., Capehorn, M. S., De Remigis, A., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01585-7 · Cited by 91
Stender, S., Frikke‐Schmidt, R., Nordestgaard, B. G., Grande, P., & Tybjærg‐Hansen, A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02576.x · Cited by 97
Self-citationClinical implications of inflammation for cardiovascular primary prevention
Libby, P., & Crea, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq022 · Cited by 91
Battistoni, A., Rubattu, S., & Volpe, M. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.06.066 · Cited by 102
Statins, inflammation and kidney disease
Krane, V., & Wanner, C. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.62 · Cited by 91
Sehestedt, T. B., Lyngbæk, S., Eugen‐Olsen, J., Jeppesen, J., Andersen, O., Hansen, T. W., Linneberg, A. R., Jørgensen, T., Haugaard, S. B., & Olsen, M. H. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.049 · Cited by 92
Observational Studies Versus Randomized Controlled Trials: Avenues to Causal Inference in Nephrology
Kovesdy, C. P., & Kalantar‐Zadeh, K. (2012) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.09.004 · Cited by 89
Wium-Andersen, M. K., Ørsted, D. D., & Nordestgaard, B. G. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt120 · Cited by 89
Self-citationNg, T. K. S., Fam, J., Feng, L., Cheah, I. K.-M., Tan, C. T.-Y., Nur, F., Wee, S. T., Goh, L. G., Chow, W. L., Ho, R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0696-y · Cited by 93
Elevated C-Reactive Protein in Atherosclerosis — Chicken or Egg?
Schunkert, H., & Samani, N. J. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807235 · Cited by 87
Li, Z., Chung, A. C., Zhou, L., Huang, X. R., Liu, F., Fu, P., Fan, J., Szalai, A. J., & Lan, H. Y. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.42 · Cited by 95
Genetics of Coronary Artery Disease
Musunuru, K., & Kathiresan, S. (2010) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082509-141637 · Cited by 83
Nonfasting Glucose, Ischemic Heart Disease, and Myocardial Infarction
Benn, M., Tybjærg-Hansen, A., McCarthy, M. I., Jensen, G. B., Grande, P., & Nordestgaard, B. G. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.043 · Cited by 84
Self-citationSode, B. F., Allin, K. H., Dahl, M., Gyntelberg, F., & Nordestgaard, B. G. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121636 · Cited by 84
Self-citationNordestgaard, A. T., & Nordestgaard, B. G. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw325 · Cited by 79
Self-citationRole of C-reactive protein in cerebrovascular disease: a critical review
Napoli, M. D., Elkind, M. S. V., Godoy, D. A., Singh, P., Papa, F., & Popa‐Wagner, A. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.159 · Cited by 94
C-Reactive Protein and Risk of Venous Thromboembolism in the General Population
Zacho, J., Tybjærg‐Hansen, A., & Nordestgaard, B. G. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.198473 · Cited by 88
Self-citationHubacek, J. A., Peasey, A., Pikhart, H., Stavek, P., Kubinova, R., Marmot, M., & Bobak, M. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.01.008 · Cited by 83
Thomas, P. E., Vedel‐Krogh, S., Kamstrup, P. R., & Nordestgaard, B. G. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad055 · Cited by 85
Self-citationShah, T., Newcombe, P., Smeeth, L., Addo, J., Casas, J. P., Whittaker, J., Miller, M. A., Tinworth, L., Jeffery, S., Strazzullo, P., et al. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.957431 · Cited by 80
Simon, T. G., Trejo, M. E. P., McClelland, R. L., Bradley, R. D., Blaha, M. J., Zeb, I., Corey, K. E., Budoff, M. J., & Chung, R. T. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.046 · Cited by 89
C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach
Dahl, M., Vestbo, J., Zacho, J., Lange, P., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2011) · Thorax · doi:10.1136/thx.2009.131193 · Cited by 83
Self-citationAlghadir, A. H., Gabr, S. A., & Al-Eisa, E. S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2545168 · Cited by 71
Miller, M. W., Maniates, H., Wolf, E. J., Logue, M. W., Schichman, S. A., Stone, A., Milberg, W., & McGlinchey, R. E. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.022 · Cited by 87
Kushner, I., Samols, D. R., & Magrey, M. (2010) · Arthritis Care & Research · doi:10.1002/acr.20052 · Cited by 91
Jackson, N., Atar, D., Borentain, M., Breithardt, G., van Eickels, M., Endres, M., Fraass, U., Friede, T., Hannachi, H., Janmohamed, S., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv213 · Cited by 76
Brøndum-Jacobsen, P., Benn, M., Afzal, S., & Nordestgaard, B. G. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv078 · Cited by 83
Self-citationMcFadyen, J. D., Zeller, J., Potempa, L. A., Pietersz, G. A., Eisenhardt, S. U., & Peter, K. (2020) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-41769-7_20 · Cited by 84
Ronit, A., Haissman, J. M., Kirkegaard-Klitbo, D. M., Kristensen, T. S., Lebech, A., Benfield, T., Gerstoft, J., Ullum, H., Køber, L., Kjær, A., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-2026-9 · Cited by 83
Self-citationYan, A. T.-K., Yan, R. T., Cushman, M., Redheuil, A. B., Tracy, R. P., Arnett, D. K., Rosen, B. D., McClelland, R. L., Bluemke, D. A., & Lima, J. A. C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehp454 · Cited by 82
Lepper, P. M., Kleber, M. E., Grammer, T. B., Hoffmann, K., Dietz, S., Winkelmann, B. R., Boehm, B. O., & März, W. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.001 · Cited by 79
Metadata
- Authors
- Zacho, J., Tybjærg-Hansen, A., Jensen, J. S., Grande, P., Sillesen, H., & Nordestgaard, B. G.
- Affiliations
- University of Copenhagen (DK)
- Herlev Hospital (DK)
- Rigshospitalet (DK)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-10-30
- Volume
- 359
- Issue
- 18
- Pages
- 1897-1908
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2081615427
- Cited by
- 839
- References
- 36
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 21 · 2023: 21 · 2022: 26 · 2021: 25 · 2020: 33 · 2019: 25 · 2018: 28 · 2017: 40 · 2016: 48 · 2015: 44 · 2014: 61 · 2013: 56 · 2012: 76
- FWCI
- 102.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- C-reactive protein, ischemic heart disease, ischemic cerebrovascular disease, ischemic vascular disease, CRP gene polymorphisms, apolipoprotein E, high-sensitivity CRP, genetic association, cholesterol levels, causal relationship
- MeSH terms
- C-Reactive Protein, Cerebrovascular Disorders, Cross-Sectional Studies, Female, Humans, Male, Polymorphism, Genetic, Risk Factors, Cohort Studies, Biomarkers, Myocardial Ischemia, Genetic Predisposition to Disease, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.